If future studies confirm that aberrantly enhanced Aβ signaling is a common driver of PTH hypersecretion, interfering with this pathway could form the basis of a new and actionable therapeutic approach for hyperparathyroidism, particularly in cases where surgical management is not indicated, appropriate, or safe (27). The gene discussed is PTH; the disease is hyperparathyroidism.